Alex Filicevas was appointed as the first-ever Executive Director of the World Bladder Cancer Patient Coalition (WBCPC) in October 2019. He has been leading the organisations’ efforts to foster an international community of bladder cancer patient advocates. Alex brings with him great past experience in leading EU affairs work at Europe’s largest international federation of cancer patient organisations. Prior to this, he also worked as a consultant for many years, supporting a number of private and non-profit organisations in their EU policy and advocacy activities within healthcare.
Marie Magenhann Cueto joined the World Bladder Cancer Patient Coalition (WBCPC) in 2021 as Communications Trainee and in 2022 became a Communications and Community Engagement Assistant. Of French and Spanish nationality, educated at the European School of Brussels II and in the Universities of Maastricht (Netherlands) and Pompeu Fabra (Spain), Marie has shown from an early age an interest in the field of politics and communication.
Before joining WBCPC, Marie led media communications for the European Year of Cultural Heritage at the European Commission.
Theodoros Yfantis joined the World Bladder Cancer Patient Coalition (WBCPC) in 2021 as Project Coordinator. He brings several years of experience in the healthcare sector as a consultant at a leading global communications agency, the Standing Committee of European Doctors (CPME), and a more specific patient advocacy area with the largest European pan-cancer organisation.
He is a strong project manager and has participated in Horizon2020 and Innovative Medicines Initiative (IMI) in various capacities on projects funded by the European Commission.
Sara Badreh Wirström joined the World Bladder Cancer Patient Coalition (WBCPC) in 2026 as Project Manager for the BCLEAR project. She is the founder and CEO of BW Consultancy AB and brings extensive experience in health policy, advocacy and multi-stakeholder project management. Sara holds a Master’s degree in Molecular Life Sciences and spent three years at the Karolinska Institute in Sweden, where she worked as a researcher in the field of immunology.
Alongside her scientific background,
